PURPOSE: We evaluated the presentation, methods of diagnosis and treatment of pelvic recurrence following radical cystectomy for @entity1606 of the bladder. MATERIALS AND METHODS: We reviewed the records of 33 @entity1 who underwent radical cystectomy for @entity1606 between May 1960 and August 1995 at our @entity5 center and who later had pelvic recurrence. RESULTS: The majority of @entity1 underwent cystectomy for clinically advanced @entity1606 . Median time from cystectomy to recurrence was 10 months. Of the @entity1 25 were symptomatic (76%) at the time recurrence was diagnosed. Recurrence was discovered by digital rectal examination in 4 asymptomatic @entity1 (12%) and by routine pelvic imaging in 2. Treatment included chemotherapy, surgery or radiation (alone or in combination). Of the 33 @entity1 29 died of progressive disease with a median survival of 7 months from the time of recurrence, and 4 remained free of disease at 7, 14, 26 and 95 months after local recurrence. Despite the poor survival rate following treatment 11 of 14 @entity1 had complete resolution of symptoms following chemotherapy. CONCLUSIONS: The prognosis of @entity1 with local recurrence is poor regardless of therapy. These recurrences are often symptomatic but careful post-cystectomy @entity5 surveillance, including digital rectal examination and pelvic imaging, provides an opportunity to diagnose local recurrences when they may be amenable to therapy. Systemic chemotherapy offers excellent palliation for symptomatic @entity1 .

Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for XXXX of the bladder.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1606 :: ('MESH:D002295', 'Disease') :: ['transitional cell carcinoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'cancer']
@entity1606 :: (MESH:D002295,Disease) :: ['transitional cell carcinoma']
